Fundraising Fox
Scout Bio Inc
AcquiredPhiladelphia, US · Founded 2016 · Delaware corporation · 6,832 employees on LinkedIn · 5 known investors
Find your way into Scout Bio Inc
Sign up to see every warm intro you have to Scout Bio Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scout Bio Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals. The company was acquired by animal health firm Ceva in early 2024, and its work now operates as Ceva's biotechnology campus in Philadelphia.
Founders & leadership
Board
Investors · 5
How we know: Companion Fund's portfolio page · Not right? Tell us
How we know: Correlation Ventures's portfolio page · Not right? Tell us
How we know: Digitalis Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$34M disclosed across 3 rounds · 2018–2021
▶$4.8MraisedOct 2021 · 6 investors · OtherRule 506(b)
- Damian LismoreExecutive Officer
- Nancy HongDirector
- Cindy ColeDirector
- Mark HeffermanExecutive Officer, Director
- Aditya KohliDirector
- Patrick HeronDirector
- Offering amount
- $13M
- Amount sold
- $4.8M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$20MraisedApr 2019 · 6 investors · OtherRule 506(b)
- Aditya KohliDirector
- Mark HeffermanExecutive Officer, Director
- Tadataka YamadaDirector
- Patrick HeronDirector
- Cindy ColeDirector
- Nancy HongDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$9.3MraisedMar 2018 · 4 investors · OtherRule 506(b)
- Remy DurandDirector
- Krishna PoluExecutive Officer, Director
- Tadataka YamadaDirector
- Kevin MahoneyDirector
- Patrick HeronDirector
- Offering amount
- $9.3M
- Amount sold
- $9.3M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Scout Bio Inc.
Frequently asked questions
- What does Scout Bio Inc do?
- Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals. The company was acquired by animal health firm Ceva in early 2024, and its work now operates as Ceva's biotechnology campus in Philadelphia.
- Who are Scout Bio Inc's investors?
- Scout Bio Inc's investors include Companion Fund, Correlation Ventures, Digitalis Ventures, Frazier Life Sciences, RiverVest Venture Partners.
- How much funding has Scout Bio Inc raised?
- Scout Bio Inc has disclosed $34M raised across 3 rounds.
- Where is Scout Bio Inc headquartered?
- Scout Bio Inc is headquartered in Philadelphia, US.